Account
Helios Media assigned revenue monetisation for Music F Fatafati
MUMBAI: Fatafati, a 24 hour Bangla music channel, has handed its revenue mandate to Helios Media with immediate effect.
The channel that was launched last year has achieved the lead position among the youth of West Bengal. Amongst the youth (15-24 age-group) Music F Fatafati garnered 743 GVTs as against 709 GVTs of Sangeet Bangla, as per TAM, week 44 , 15-24 , WB market.
Promoter of the channel Siddarth Misra said, “We created a unique position for Music F Fatafati by bringing in 3D animated characters and cartoon shorts as interstitials for the first time in the Bangla market. Our characters are extremely popular among the youth and we have managed to dislodge the reigning channel Sangeet Bangla from its position this week. We are confident that our alignment with Helios Media will help FataFati in realising its full potential.”
The creator of the channel Vikas Varma added, “With the heavy firepower of Helios Media as part of the Fatafati armoury, Bengals #1 music TV channel will achieve its true potential and conquer new sales frontiers in Bengal. A very warm Fatafati welcome to Helios Media.”
Helios Media COO Bala Iyengar said, “Just like how in Hindi market, youth TG is addressed with music channels, the reflection of it in its regional counterparts is not appropriately valued. It is all generally clubbed under one umbrella called ‘regional.’ With our proven track-record of building true-value for the channels we work with, we are confident that we will be in a position to raise the bar for Fatafati as well. In a similar space, MTunes HD is among the top 3 channels on commercial inventory week after week due to selling prowess of Helios Media.”
Helios Media also handles revenue monetisation for FoodFood, EPIC, Channel X and Fashion TV.
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








